Shares of UnitedHealth Group (NYSE: UNH) were pulling back in December due to a backlash against the company following the ...

Shares of what may be America's most powerful healthcare company have declined due to controversy and regulatory threats.

Revenue at the UnitedHealth Group was more than $299 billion through September — which is a record high and up from $277 ...

UnitedHealth Group faces rising costs and tough negotiations with governments it works with to provide elderly and poor ...

We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks. In this article, we are ...

UnitedHealth Group stock, the healthcare sector leader, took a significant hammering as panic sellers bailed out. See why I ...

UnitedHealth Group reports Q4 financial results Jan. 16. A look at the estimates and how the company is navigating itself ...

UnitedHealth Group and Amedisys agreed to extend the deadline to complete their $3.3 billion merger, after the Department of Justice moved to block the deal.

UnitedHealth Group (UNH) concluded the recent trading session at $507.80, signifying a -0.43% move from its prior day's close.

The killing of UnitedHealthcare CEO Brian Thompson has sparked extraordinary public interest in the nation’s health insurance industry. Much of the outcry ...